Chiron and LabCorp Sign Licensing Agreement for Hepatitis C Plasma Testing; Agreement Further Expands Licensing of Chiron Technology

Chiron Corporation and Laboratory Corporation of America(R) Holdings (LabCorp(R)) announced today that they have signed a licensing agreement for Chiron's hepatitis C virus (HCV) intellectual property for nucleic acid testing (NAT).

Please to read the entire article.

You must be logged in to post a comment Login